389 related articles for article (PubMed ID: 19452403)
1. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
Targher G; Chonchol M; Miele L; Zoppini G; Pichiri I; Muggeo M
Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
Salt WB
J Insur Med; 2004; 36(1):27-41. PubMed ID: 15104027
[TBL] [Abstract][Full Text] [Related]
5. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
6. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
7. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and nonalcoholic fatty liver disease.
Ramesh S; Sanyal AJ
Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
[TBL] [Abstract][Full Text] [Related]
9. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
Cave M; Deaciuc I; Mendez C; Song Z; Joshi-Barve S; Barve S; McClain C
J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
[TBL] [Abstract][Full Text] [Related]
11. Evolving trends in nonalcoholic fatty liver disease.
Delgado JS
Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease.
Hjelkrem MC; Torres DM; Harrison SA
Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease and the metabolic syndrome.
Marchesini G; Babini M
Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
Nugent C; Younossi ZM
Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.
Targher G; Byrne CD
Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
18. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
Schwimmer JB
Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
Carter-Kent C; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]